| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Edward M Basile is Director at TMDX. From May 2019 to May 2026, the filings on record show 1 open-market purchase and 11 sales. Edward M Basile's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $390K at current prices.
Historically, Edward M Basile's trades have earned a middling insider score of 67/100 across 11 rated trades. Over a 12-month horizon, 63.6% of those trades were profitable, with an average 12-month return of +15.4%.
The TMDX filings lean toward selling, a net 48,292 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2023 | TMDX Transmedics Group, Inc. | Director | Sell | 5,000 | $78.06 | $390,315.00 | -21.9% | -7.2% | +13.8% | |
| May 6, 2019 | TMDX Transmedics Group, Inc. | Director | Buy | 8,500 | $16.00 | $136,000.00 | +59.4% | - | - |